 - Serologic testing within 4 weeks prior to starting study treatment with negative results for hepatitis C virus HCV, human immunodeficiency virus HIV and hepatitis B virus HBV demonstrated by negative hepatitis B core antibody HBc Ab and hepatitis B surface antigen HbsAg 